Professional Analysts at BMO Capital Reiterate their Market Perform rating for United Natural Foods (UNFI). The Price Objective Given is $41; Shorts at Neurotrope (NTRP) Raised By 4.87%

June 16, 2018 - By Hazel Jackson

Neurotrope, Inc. (NASDAQ:NTRP) Logo

Neurotrope Inc (NASDAQ:NTRP) had an increase of 4.87% in short interest. NTRP’s SI was 96,900 shares in June as released by FINRA. Its up 4.87% from 92,400 shares previously. With 24,300 avg volume, 4 days are for Neurotrope Inc (NASDAQ:NTRP)’s short sellers to cover NTRP’s short positions. The SI to Neurotrope Inc’s float is 1.81%. It closed at $10.15 lastly. It is down 50.16% since June 16, 2017 and is uptrending. It has outperformed by 37.59% the S&P500. Some Historical NTRP News: ; 10/05/2018 – NEUROTROPE INC – ON MAY 4 NEUROTROPE BIOSCIENCE EXECUTED A SERVICES AGREEMENT WITH WORLDWIDE CLINICAL TRIALS; 07/05/2018 Neurotrope, In Consultation With Leading Neuroscientists, Completes the Study Design for its Confirmatory Phase 2 Trial in Advanced Alzheimer’s Patients; 10/05/2018 – NEUROTROPE – DEAL RELATES TO SERVICES FOR CONFIRMATORY PHASE 2 STUDY OF BRYOSTATIN IN TREATMENT OF MODERATELY SEVERE TO SEVERE ALZHEIMERS DISEASE

In a research note issued to clients and investors on 8 June, United Natural Foods (NASDAQ:UNFI) stock Market Perform was reconfirmed by Analysts at BMO Capital. They currently have a $41 target on the stock. BMO Capital’s target means a potential upside of 1.11% from the company’s previous close.

Investors sentiment increased to 1.36 in Q1 2018. Its up 0.28, from 1.08 in 2017Q4. It is positive, as 21 investors sold United Natural Foods, Inc. shares while 80 reduced holdings. 54 funds opened positions while 83 raised stakes. 49.01 million shares or 5.09% less from 51.64 million shares in 2017Q4 were reported. State Treasurer State Of Michigan holds 18,400 shares. Retail Bank Of Nova Scotia accumulated 40,000 shares or 0.01% of the stock. Aqr Cap Mgmt Ltd holds 0.01% or 251,419 shares. Menta Ltd Liability Corporation accumulated 12,086 shares. Hussman Strategic owns 50,000 shares or 0.59% of their US portfolio. Texas Permanent School Fund accumulated 33,366 shares. Eqis Capital Mgmt Incorporated invested in 6,184 shares or 0.01% of the stock. Rodgers Brothers has invested 0.1% in United Natural Foods, Inc. (NASDAQ:UNFI). 5,300 are held by Sumitomo Mitsui Trust. 58,600 were reported by Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mgmt. Ubs Asset Americas Incorporated reported 0% in United Natural Foods, Inc. (NASDAQ:UNFI). Wealthtrust holds 0.01% or 444 shares. Advantus Mngmt reported 0.01% in United Natural Foods, Inc. (NASDAQ:UNFI). Balyasny Asset Management Ltd Liability Company stated it has 0.03% of its portfolio in United Natural Foods, Inc. (NASDAQ:UNFI). Riverbridge Prtn Lc invested in 1.22% or 1.56M shares.

United Natural Foods, Inc., together with its subsidiaries, distributes natural, organic, and specialty foods and non-food products in the United States and Canada. The company has market cap of $2.05 billion. The firm operates through three divisions: Wholesale, Retail, and Manufacturing and Branded Products. It has a 13.21 P/E ratio. The Wholesale division offers grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care products.

Since December 18, 2017, it had 0 insider buys, and 8 insider sales for $4.52 million activity. 6,680 shares were sold by Traficanti Joseph J, worth $314,695 on Thursday, May 17. FUNK MICHAEL S had sold 5,625 shares worth $250,650 on Thursday, March 15. On Monday, December 18 HEFFERNAN JAMES P sold $394,236 worth of United Natural Foods, Inc. (NASDAQ:UNFI) or 7,580 shares. SPINNER STEVEN sold $2.43 million worth of United Natural Foods, Inc. (NASDAQ:UNFI) on Tuesday, January 2. Green Paul Scott sold $171,323 worth of stock or 3,473 shares. The insider ROY PETER sold $175,361. Griffin Sean had sold 12,351 shares worth $610,263 on Tuesday, January 2.

The stock decreased 0.90% or $0.37 during the last trading session, reaching $40.55. About 506,089 shares traded or 7.43% up from the average. United Natural Foods, Inc. (NASDAQ:UNFI) has risen 13.26% since June 16, 2017 and is uptrending. It has outperformed by 0.69% the S&P500. Some Historical UNFI News: 14/05/2018 – United Natural Foods COO Sean Griffin to Retire Oct. 1; 08/03/2018 – UNITED NATURAL FOODS RAISES FISCAL 2018 GUIDANCE; 08/03/2018 – UNITED NATURAL 2Q EPS 99C; 08/03/2018 – UNITED NATURAL FOODS INC UNFI.O SEES FY 2018 SHR ABOUT $3.27 TO $3.35; 14/05/2018 – UNITED NATURAL FOODS-SEAN GRIFFIN, CHIEF OPERATING OFFICER, WILL TRANSITION FROM HIS CURRENT ROLE ON AUGUST 1, 2018 AND RETIRE FROM COMPANY ON OCT 1; 09/03/2018 – United Natural Volume Surges Almost 21 Times 20 Day Average; 11/04/2018 – Starco Brands and Nation’s Largest Health Food Distributor UNFI Expand Distribution of Breathe(TM) Cleaning Products; 09/03/2018 – UNITED NATURAL FOODS INC UNFI.O : DEUTSCHE BANK RAISES TARGET PRICE TO $52 FROM $50; RATING HOLD; 14/05/2018 – United Natural Foods, Inc. Announces Organizational Changes; 08/03/2018 – UNITED NATURAL FOODS INC UNFI.O FY2018 SHR VIEW $2.94, REV VIEW $9.92 BLN — THOMSON REUTERS l/B/E/S

Among 26 analysts covering United Natural Foods (NASDAQ:UNFI), 8 have Buy rating, 4 Sell and 14 Hold. Therefore 31% are positive. United Natural Foods has $76 highest and $3200 lowest target. $46.13’s average target is 13.76% above currents $40.55 stock price. United Natural Foods had 93 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of United Natural Foods, Inc. (NASDAQ:UNFI) earned “Hold” rating by Oppenheimer on Tuesday, June 6. The firm has “Neutral” rating given on Tuesday, June 7 by Piper Jaffray. The firm has “Buy” rating by Buckingham Research given on Monday, October 19. As per Thursday, November 5, the company rating was downgraded by Piper Jaffray. The firm earned “Hold” rating on Friday, March 9 by Jefferies. The rating was maintained by BMO Capital Markets with “Hold” on Friday, December 8. The company was downgraded on Wednesday, July 22 by Morgan Stanley. On Tuesday, March 8 the stock rating was maintained by Canaccord Genuity with “Buy”. The stock of United Natural Foods, Inc. (NASDAQ:UNFI) has “Overweight” rating given on Saturday, August 22 by Stephens. On Sunday, August 23 the stock rating was maintained by Deutsche Bank with “Hold”.

More notable recent United Natural Foods, Inc. (NASDAQ:UNFI) news were published by: Nasdaq.com which released: “What Shareholders Missed in United Natural Foods’ Earnings” on June 14, 2018, also Nasdaq.com with their article: “Breatheâ„¢ – Award Winning Household Aerosol Cleaning Line – Continues to Expand Distribution” published on June 14, 2018, Seekingalpha.com published: “United Nature Foods -6% after uninspiring conference call” on June 07, 2018. More interesting news about United Natural Foods, Inc. (NASDAQ:UNFI) were released by: Seekingalpha.com and their article: “United Natural Foods, Inc. (UNFI) CEO Steve Spinner on Q3 2018 Results – Earnings Call Transcript” published on June 07, 2018 as well as Nasdaq.com‘s news article titled: “What Happened in the Stock Market Today” with publication date: June 07, 2018.

Neurotrope, Inc., a biopharmaceutical company, focuses on developing therapeutic and diagnostic technologies in the field of neurodegenerative diseases in the United States. The company has market cap of $80.26 million. The companyÂ’s lead product candidate is bryostatin-1, a natural product isolated from a marine invertebrate organism, which is in a Phase II trial for the treatment of moderate to severe AlzheimerÂ’s dementia, as well as in preclinical studies as a treatment for Fragile X Syndrome, Niemann-Pick Type C disease, and Rett Syndrome. It currently has negative earnings. It has a license agreement with the Leland Stanford Junior University to sublicense Bryologs that are structural derivatives of Bryostatin for use in the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardioprotection, and traumatic brain injury; and technology license and services agreement with Cognitive Research Enterprises, Inc. and its affiliate, NRV II, LLC.

More news for Neurotrope, Inc. (NASDAQ:NTRP) were recently published by: Benzinga.com, which released: “Benzinga’s Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time” on June 01, 2018. Benzinga.com‘s article titled: “Benzinga’s Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts …” and published on May 30, 2018 is yet another important article.

United Natural Foods, Inc. (NASDAQ:UNFI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>